Tianlongkechuanling Inhibits Pulmonary Fibrosis Through Down-Regulation of Arginase-Ornithine Pathway

• Main Authors: Lili Zhang (Author), Sihao Qu (Author), Lu Wang (Author), Chunguo Wang (Author), Qinghe Yu (Author), Zhimin Zhang (Author), Yirui Diao (Author), Binbin Zhang (Author), Yadong Li (Author), Yuanyuan Shi (Author), Peng Wang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Pulmonary Fibrosis (PF) is an interstitial lung disease characterized by excessive accumulation of extracellular matrix in the lungs, which disrupts the structure and gas exchange of the alveoli. There are only two approved therapies for PF, nintedanib (Nib) and pirfenidone. Therefore, t...